New genetic evidence suggests that targeting GIPR and GLP1R can help reduce harmful drinking patterns while improving liver and metabolic health and open the door to...
Pathogen C. diff – the most common cause of medically related infectious diarrhea – survives and grows using compounds that kill microorganisms in the human intestine,...
Researchers at the Center for Genome Regulation (CRG) have discovered that metabolic enzymes, known for their roles in energy production and nucleotide synthesis, have taken on...
New evidence suggests that the antiviral drug molnupiravir, used to treat patients with COVID-19, appears to be causing SARS-CoV-2 to mutate and evolve, and that some...
In a recently published study, Nature Biomedical EngineeringA group of researchers optimized prime editing (PE) to efficiently correct the cystic fibrosis (CF) transmembrane conductance regulator (CFTR)...
Researchers led by Yasuhiro Murakawa of the RIKEN Center for Integrative Medical Sciences (IMS) and Kyoto University, and IFOM ETS in Italy, have discovered several unusual...
Recent Comments